粉样蛋白轻链 (AL) 粉样蛋白病的多域终点的开发和验证的途径
James Signorovitch1, Jialu Zhang2, David Brown3
1Analysis Group, Boston, USA.
Therapeutic innovation & regulatory science
|April 17, 2024
概括
开发免疫球蛋白轻链 (AL) 粉症的多域终点 (MDEs) 对于推进新疗法至关重要. 该倡议旨在为这种罕见的多系统疾病的临床试验创建验证的终点.
科学领域:
- 血液学 血液学 血液学
- 临床试验 临床试验
- 药物开发 药物开发
背景情况:
- 免疫球蛋白轻链 (AL) 粉症是一种罕见的血细胞疾病,由粉样纤维沉积引起器官损伤.
- 对这种异质性疾病的治疗开发需要标准化的临床试验终点.
研究的目的:
- 提出一种开发和验证AL氨基粉症临床试验的多域终点 (MDEs) 的途径.
- 通过跨受影响器官和生命影响的领域特定终点确定构建MDEs的策略.
主要方法:
- 一个公私伙伴关系 (粉症研究联盟和FDA) 在2020年成立了粉症论坛.
- 统计小组审查了来自器官特定工作组的候选终点,以探索MDE构建方法.
主要成果:
- 考虑了通过整合特定领域的终点来构建MDEs的各种方法.
- 确定需要未来的研究来验证MDEs使用自然史和临床试验数据.
结论:
- 经过验证的MDEs对于推进以患者为中心的AL氨基粉症药物开发至关重要.
- 终点选择应以监管背景,患者群体和药物开发的治疗机制为指导.
更多相关视频
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
8.8K
10:04Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
Published on: October 20, 2017
13.4K
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
